You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
双成药业(002693.SZ):公司药品生产许可证变更
格隆汇 06-14 17:58

格隆汇6月14日丨双成药业(002693.SZ)公布,公司近日取得海南省药品监督管理局发的《药品生产许可证》此次主要涉及生产范围的变更,新增生产范围:醋酸奥曲肽、加压素、硼替佐米变更后的《药品生产许可证》信息主要容如下:

生产地址和生产范围:海口市秀英区兴国路16原料药(胸腺法新,艾塞那肽,比伐芦定、依替巴肽、胸腺五肽、生长抑素、醋酸曲普瑞林醋酸奥曲肽、加压素、硼替佐米),冻干粉针剂(三车间、四车间),小容量注射剂(含卡式)大容量注射剂***

此次《药品生产许可证》涉及生产范围的变更,有利于未来丰富公司产品的结构,更好满足市场需求。短期内对公司业绩无重大影响,敬请投资者注意投资风险。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account